METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD)
Clinical trials for METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD) explained in plain language.
Never miss a new study
Get alerted when new METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD) trials appear
Sign up with your email to follow new studies for METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Fasting two days a week could shrink fatty liver, new study hopes to prove
Disease control Recruiting nowThis study tests whether a 5:2 intermittent fasting diet (eating only about 600 calories on two non-consecutive days each week) can reduce liver fat in people with metabolic dysfunction-associated steatotic liver disease (MASLD). 120 adults with obesity and significant liver fat …
Matched conditions: METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD)
Phase: NA • Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 23, 2026 22:01 UTC
-
Short bursts of exercise may boost liver health in overweight adults
Symptom relief Recruiting nowThis study looks at whether high-intensity interval training (HIIT) can improve liver health in adults aged 18 to 59 who are overweight or have obesity. Thirty participants will either do HIIT for 8 weeks or continue their usual routine. The goal is to see if exercise can reduce …
Matched conditions: METABOLIC ASSOCIATED-DYSFUNCTION STEATOTIC LIVER DISEASE (MASLD)
Phase: NA • Sponsor: Universidad San Sebastián • Aim: Symptom relief
Last updated Jun 18, 2026 11:51 UTC